Wednesday September 8, 2010 - Erev Rosh Hashana


Generate a Custom News Feed! Click here to learn more!


Feeds

  • Aish
  • BBC - Middle East
  • Daniel Pipes
  • DEBKAfile
  • DeProgram Program
  • Dry Bones
  • Financial Times - Middle East
  • Fundamentally Freund
  • Globes
  • Globes - Israeli Stocks on Wall Street
  • Haaretz
  • Haaretz - Business
  • Haaretz - Real Estate
  • Haaretz - Sports
  • Haaretz - Travel
  • Honest Reporting
  • IOL - Middle East
  • Isi Leibler
  • Israel Hasbara Committee
  • Israel Insider
  • Israel Insider - Views
  • Israel National News (A7)
  • Israel National News (A7) - Opinion
  • Israel Video Blog
  • israelenews
  • Jerusalem Newswire
  • Jerusalem Post
  • Jerusalem Post - Jewish News
  • Jerusalem Post - Opinion
  • Jewish Daily Forward
  • Jihad Watch
  • JTA
  • Little Green Footballs
  • MEMRI Blog
  • Monsters and Critics Mideast News
  • MSNBC - Middle East
  • New York Times - Israel
  • NPR - Middle East
  • One Jerusalem
  • Shabot 6000
  • Unity Coalition for Israel
  • Washington Post - Middle East
  • World Net Daily
  • World Net Daily - Commentary
  • Yahoo - Mideast Conflict
  • Yeshiva World News
  • YNET
  • YNET - Culture
  • YNET - Opinion

    Is there a News Feed
    you'd like to see here?

    Contact Us now to let us know!

  • Globes - Israeli Stocks on Wall Street  

    It was a sweet old year for these companies
    This week marks the end of the Hebrew year, and as usual at this time, I look back at the shares that stood out in my portfolio, tracked by "Globes", over the past year - since mid-September, 2009.

    Partner drops bid in largest telecom tender
    The mobile carrier concluded that it had little chance of making a profit.

    Chip cos Wintegra, Provigent await Freescale IPO
    Two Israeli chipmakers are watching developments with Freescale before deciding on their own IPOs.

    Soltam president leaves three days after acquisition
    The resignation was apparently prearranged; Elbit Systems has already named David Marsiano's successor.

    Amdocs CEO to step down
    Dov Baharav's retirement will take effect in the first quarter of 2011, and he will also resign as company director.

    Emblaze confirms Formula sale
    Polish computing company Asseco is buying Emblaze's 49% stake for $139 million.

    IncrediMail shares jump on dividend
    The share price rose 8.6% on the TASE today after rising 2.6% on Nasdaq on Friday.

    Gov't to limit mobile cos exit fines
    The high cost of cancelling contracts has made switching carriers difficult for subscribers.

    Cellcom sees NIS 320m sliced off net profit
    The company is considering legal action over the cut in interconnect fees.

    Teva loses Evista appeal
    The company won't market a generic version of Eli Lilly's osteoporosis drug Evista.

    No winner yet in Comverse land sale
    Sources: Comverse will hold an auction next week, and will likely announce the winner by the end of the month.

    Elbit Systems buys Mikal subsidiaries, not Mikal
    After buying all or most of three subsidiaries, Elbit Systems will sell its existing stake in Mikal.

    Communications minister slams mobile phone cos as he cuts rates
    Moshe Kahlon cut the interconnect fee 73% to to NIS 0.068 per minute, effective January 1.

    Will the banks flood the market with Tower shares?
    In its second quarter financials, Bank Hapoalim recorded Tower's convertible capital notes as an asset available for sale for the first time.

    Emblaze in talks to sell Formula stake
    The buyer is apparently Asseco of Poland. It is unclear whether Emblaze founder Eli Reifman will benefit from the deal.

    Not resigned to Harari's resignation
    Intel gets in to iPhones and iPads, for obvious reasons. Dr. Eli Harari gets out of SanDisk, and it is not yet clear why.

    Partner turns to court to halt rate reduction
    The mobile carrier wants the court to order the Communications Ministry to hand over all documents about the connectivity fees hearing.

    InSightec system treats first prostate cancer patients
    The ExAblate system has been used until now for the treatment of uterine fibroids and bone metastases.

    EDT takeover gives Elbit Imaging a profit
    An accounting gain of NIS 385 million for the closing of the acquisition of EDT Retail Trust (ASX: EDT) in June secured a good second quarter financial report for the company.

    Indian project thaw unfreezes Ceragon orders
    The communications equipment firm won a multimillion dollar order.

    Welcome Guest!
    Click here to create or login to your FREE
    Israel Net Daily Account!

    Free News Feed!

    Subscribe to our free newsletter!


    © Copyright 2010, Israel Net Daily. All rights reserved.